SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0000950170-23-034818
Filing Date
2023-07-26
Accepted
2023-07-26 17:26:43
Documents
10
Effectiveness Date
2023-07-26

Document Format Files

Seq Description Document Type Size
1 S-3ASR form_s-3_asr_2023.htm S-3ASR 1004960
2 EX-4.2 vktx-ex4_2.htm EX-4.2 913947
3 EX-5.1 vktx-ex5_1.htm EX-5.1 71630
4 EX-23.1 vktx-ex23_1.htm EX-23.1 5078
5 EX-FILING FEES vktx-exfiling_fees.htm EX-FILING FEES 155985
6 GRAPHIC img206696223_0.jpg GRAPHIC 13142
7 GRAPHIC img206696223_1.jpg GRAPHIC 13142
8 GRAPHIC img206696223_2.jpg GRAPHIC 13142
9 GRAPHIC img246856755_0.jpg GRAPHIC 11202
10 GRAPHIC img246856755_1.jpg GRAPHIC 11290
  Complete submission text file 0000950170-23-034818.txt   2238615
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-273460 | Film No.: 231114642
SIC: 2834 Pharmaceutical Preparations